IDT is buying PLX in a cash-and-stock transaction valued at 0.525 of an IDT share and $3.50 in cash for each share of PLX in a deal that was announced April 30 and received a request for more information from the FTC on July 6. IDT and PLX certified ...
The Deal Pipeline · 12/19/2012 is a leading small cap stock information site since 1999, to register for the free SmallCapReview newsletter visit Protalix BioTherapeutics (NYSE:PLX) Trading at $5.22, Up $0.71. Today announced that …
TransWorldNews · 7/6/2009
One such stock is Israel-based micro-cap by the name of Protalix BioTherapeutics Inc. (PLX), which gained 11% during trading yesterday and is up another 6% in extended trading as the Street continues to discover that the company could reap immense … · 10/14/2014
Frenkel, a former SEC enforcement lawyer who commented on the Pluristem press releases after Bloomberg ... PLX has saved her life and can certainly be classified as a medical miracle,” Or, who treated the woman, was quoted as saying in the release.
Bloomberg · ByDavid Wainer · 11/8/2012
at the Tel Aviv Stock Exchange's conference center. Pluristem's executive management team will speak about the strategic importance of its latest regulatory progress including: European Medicines Agency's selection of Pluristem's PLX cell program in ...
GlobeNewswire · 5/19/2015
Apple’s stock, even though it’s up 21% this year ... That reflected the company’s acquisitions of LSI Corp. and PLX Technology Inc. last year. Apple Inc. AAPL, -0.19% as usual, was the poster child for organic growth, with sales per share for ...
Market Watch · 4/29/2015
The Renaissance IPO Index® (IPOUSA) is a stock market index based upon a portfolio of U.S.-listed newly public companies that includes securities prior to their inclusion in core U.S. equity portfolios. The Renaissance International IPO Index® (IPOXUS ... · 8/18/2015
Avago will acquire Broadcom for $37 billion, including $17 billion in cash and $20 billion in Avago stock, the two companies announced ... LSI Corp. for $6.6 billion and smaller firms Emulex and PLX Technology, all within the past year.
CNet · 5/28/2015
The decline followed jumps in the Israel-based developer's stock price earlier this year after it announced ... to the death clearly stated that there was no connection between the PLX cell treatment and the death of the patient." Yet in the ultimate ...
Fierce Biotech · ByRyan Mcbride · 11/9/2012
Cannacord Genuity's Ritu Baral had this to say in her latest report: "We think PLX/partner Pfizer's taliglucerase (tali ... company is no longer below investors' radars, we believe the stock remains undervalued based on the potential of taliglucerase ... · 2/24/2011